ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure)

Circulation

Volumn 104, Issue 24, 2001, Pages 2996-3007

  Hunt, S A ^a   Baker, D W ^a   Chin, M H ^a   Cinquegrani, M P ^a   Feldman, A M ^a   Francis, G S ^a   Ganiats, T G ^a   Goldstein, S ^a   Gregoratos, G ^a   Jessup, M L ^a   Noble, R J ^a   Packer, M ^a   Silver, M A ^a   Stevenson, L W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARNITINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; GROWTH HORMONE; HYDRALAZINE; INOTROPIC AGENT; NITRATE; SPIRONOLACTONE; TAURINE; THYROID HORMONE; UBIDECARENONE; VASOPEPTIDASE INHIBITOR;

ADULT; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE PREDISPOSITION; HEART FAILURE; HIGH RISK POPULATION; HUMAN; MEDICAL SOCIETY; NON INVASIVE MEASUREMENT; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYNDROME; TREATMENT INDICATION;

EID: 0035846616     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4901.102568     Document Type: Review

References (47)

1. Economic impact of heart failure in the United States: Time for a different approach
2. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995
3. Epidemiology of heart failure
4. Epidemiology and prevention of cardiac failure: Framingham Study insights
5. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
6. ACC/AHA guidelines for the evaluation and management of heart failure: Report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Evaluation and Management of Heart Failure)
7. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Management of Acute Myocardial Infarction)
8. Guidelines for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease)
9. Chronic heart failure in the United States: A manifestation of coronary artery disease
10. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction: Comparison with plasma angiotensin II and endothelin-1
11. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
12. Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure
13. Effect of conditioning and deconditioning stimuli on metabolically determined blood flow in humans and implications for congestive heart failure
14. Effects of exercise training in patients with congestive heart failure: A critical review
15. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure
16. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
17. Prevention of hospitalizations for heart failure with an interactive home monitoring program
18. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure
19. Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
20. Consensus recommendations for the management of chronic heart failure
21. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
22. Effect of carvedilol on survival in severe chronic heart failure
23. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth official report: 2000
24. Implantable left ventricular assist devices
25. The REMATCH trial: Rationale, design, and end points: Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
26. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease
27. The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure
28. Congestive heart failure with normal systolic function
29. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension
30. Diastolic dysfunction as a cause of heart failure
31. Diastolic failure: Pathophysiology and therapeutic implications
32. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
33. Heart failure with normal systolic function: Update of prevalence, differential diagnosis, prognosis, and therapy
34. The effect of digoxin on mortality and morbidity in patients with heart failure
35. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
36. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors
37. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
38. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise
39. The care of dying patients: A position statement from the American Geriatrics Society
40. Heart failure: Evaluation and care of patients with left-ventricular systolic dysfunction
41. Clinical outcomes in heart failure: Report from a community hospital-based registry
42. National patterns of angiotensinconverting enzyme inhibitor use in congestive heart failure
43. Quality of care for elderly patients hospitalized with heart failure
44. Heart failure disease management: A critical review